Design and Development of Automatic Operated Seeds Sowing Machine

The area of agriculture is so wide, therefore this field requires the advance technologies in the process of sowing, cropping, cutting. This advancement in technology will not affect the quality of soil and increase the efficiency of getting crop. During the seed sowing process the feeding of seed as well as fertilizer is pour. Now a days the availability of labor is a major problem faced by farmer. We demonstrate that the easy method for seed sowing. In this work we replace complicated gear system by hall effect sensor for easier and costlier seed sowing and also reduce a need of labor. The Hall Effect sensor convert rotation into distance for which seed sowing at particular distance. Also there is adjustable system for sowing at different distance. By using this machine the sowing can be done row by row and distance will maintain. So this machine reduces their efforts and reduces the cost of seed sowing process with great efficiency and accuracy with reducement in labor requirement

Remote Data Acquisition and Visualization on an App

In order to allow power consumers to have a better understanding of their industrial electricity, it is necessary to provide them with real-time electricity information. Now a days we need to do meter reading, analysis manually. If any meter is goes down or fluctuating we need to do manual servicing and troubleshooting. It may cause meter loss, Time loss, and financial loss. The platform enables power consumers to have a better understanding of their own electricity consumption status and reasonable arrangements for use of electricity. Its deployment is very simple. For users, they do not need to change the household electricity structure. They can easily view the home electricity information and real-time monitor and control after installing power information visualization APP on their mobile phones or other mobile terminals. User interaction needs to collect power information of all equipment, and provide users with real-time electricity price and electricity information. The basic purpose of system is M-Measure, A-Analysis, R-Record, and CControl. No human intervention for data processing analysis. This is use for Power quality analysis, Identification and prevention of downtime of assets, Alarms and triggers are used for preventive control to avoid loss. Reduce the losses by monitoring and controlling the power quality. Accurate analytics depending on the load connected to the system. It supports most of all make sensors and hardware meters to work with the system. Periodical analysis of the organization for the complete energy health check-up

Heterogeneous 2.5D integration on through silicon interposer

© 2015 AIP Publishing LLC. Driven by the need to reduce the power consumption of mobile devices, and servers/data centers, and yet continue to deliver improved performance and experience by the end consumer of digital data, the semiconductor industry is looking for new technologies for manufacturing integrated circuits (ICs). In this quest, power consumed in transferring data over copper interconnects is a sizeable portion that needs to be addressed now and continuing over the next few decades. 2.5D Through-Si-Interposer (TSI) is a strong candidate to deliver improved performance while consuming lower power than in previous generations of servers/data centers and mobile devices. These low-power/high-performance advantages are realized through achievement of high interconnect densities on the TSI (higher than ever seen on Printed Circuit Boards (PCBs) or organic substrates), and enabling heterogeneous integration on the TSI platform where individual ICs are assembled at close proximity

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.

Fast and slow jump training methods induced similar improvements in measures of physical fitness in young females

This study aimed to contrast the impacts of an exercise intervention using either bounce drop jump (DJ; fast stretch-shortening cycle [SSC] exercise) or countermovement jump (CMJ; slow-SSC exercise) on measures of physical fitness in young females. A total of twenty-three young females (age: 19.7±1.0 years, height: 159.8±4.2 cm, body mass: 54.3±14.3 kg) were randomly assigned to either DJ (n=12) or CMJ (n=11) training, which spanned six weeks. Pre- and post-training assessments were conducted for 10 m and 30 m linear sprints, change-of-direction speed (CODS), CMJ, DJ (jump height, contact time, reactive strength index [RSI]), standing long jump (SLJ), triple-hop distance, and isometric strength. Apart from the variance in jump technique, both interventions were standardized in terms of total repetitions, intensity, and surface type. No significant group × time effect was observed in any dependent variables (all p>0.05). A significant time effect was observed in 10 m (p<0.001, ES = 0.70) and 30 m (p<0.001, ES = 0.79) linear sprint, CMJ height (p=0.012, ES = 0.34), DJ contact time (p=0.012, ES = 0.34), and triple-hop distance (p=0.006, ES = 0.38). Both DJ and CMJ training interventions led to comparable improvements in linear sprints, CMJ height, DJ contact time, and triple-hop distance. These findings suggest that the duration of ground contact during intervention exercises (i.e., fast vs. slow SSC) did not significantly influence initial (six-week) physical fitness adaptations in young females. However, extending these results to highly-trained groups (e.g., athletes) warrants further investigation

Development and Validation of UV-Spectrophotometric Method for Simultaneous Estimation of Amlodipine Besylate and Hydrochlorothiazide in Combined Dosage Form Including Stability Study

ABSTRACT: Two simple, rapid, precise and accurate spectrophotometric methods have been developed for determination of Amlodipine Besylate (AMB) and Hydrochlorothiazide (HCTZ) by simultaneous equation method and stability study method in combined tablet dosage form. The simultaneous equation method is based on measurement of absorbance at 238 nm and 271 nm as two wavelengths selected for quantification of Amlodipine Besylate and Hydrochlorothiazide. The method obeyed Beer&apos;s law in the concentration range of 5-30 μg/ml for Amlodipine and 2.5-15 μg/ml for Hydrochlorothiazide. Amlodipine and Hydrochlorothiazide (Marketed Formulation) were subjected to stress degradation under different conditions recommended by ICH. The proposed methods were validated and can be applied successfully for routine quality control analysis of AMB and HCTZ in bulk and pharmaceutical formulation